The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats - PubMed (original) (raw)
The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats
M E Wewers et al. Brain Res. 1999.
Abstract
The effect of chronic nicotine administration on (1) antinociception; (2) opioid receptor binding; and (3) met-enkelphalin levels in discrete brain regions in rats was investigated. Male and female Sprague-Dawley rats were treated with nicotine 0.3 mg/kg, 0.1 mg/kg, or saline three times a day subcutaneously during a 14-day protocol. Antinociception was measured by hotplate (HP) test on days 1, 2, 7, 10 and 14. After completion of the protocol, mu-opioid receptors were analyzed by [3H]-DAMGO binding studies and met-enkelphalin levels were determined by radioimmunoassay. Results indicated that hot-plate latency increased during the first 2 days of nicotine administration for male and female rats who were treated with 0.3 mg/kg nicotine. There was an up-regulation of mu-receptors (increased Bmax) in the striatum of rats treated with 0.3 mg/kg nicotine, compared to 0. 1 mg/kg nicotine and saline groups. An interaction effect of group by gender was noted. After 14 days of chronic nicotine administration, met-enkelphalin levels were significantly lower in striatum and midbrain of animals treated with 0.3 mg/kg nicotine, as compared to controls. These results suggest that chronic nicotine administration, in doses representative of human smoking, produces antinociception initially, and is accompanied by an upregulation of micro-opioid receptors in the striatum of rats. In addition, nicotine-induced tolerance to antinociception may be associated with a decrease in met-enkelphalin level over a period of time.
Copyright 1999 Published by Elsevier Science B.V.
Similar articles
- Nicotine and opioid co-dependence: Findings from bench research to clinical trials.
Custodio L, Malone S, Bardo MT, Turner JR. Custodio L, et al. Neurosci Biobehav Rev. 2022 Mar;134:104507. doi: 10.1016/j.neubiorev.2021.12.030. Epub 2021 Dec 27. Neurosci Biobehav Rev. 2022. PMID: 34968525 Free PMC article. Review. - Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke.
Simons CT, Cuellar JM, Moore JA, Pinkerton KE, Uyeminami D, Carstens MI, Carstens E. Simons CT, et al. Neurosci Lett. 2005 Dec 2;389(2):71-6. doi: 10.1016/j.neulet.2005.07.025. Neurosci Lett. 2005. PMID: 16095820 - Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.
Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M, Kishioka S. Kiguchi N, et al. Brain Res. 2008 Jan 16;1189:70-7. doi: 10.1016/j.brainres.2007.10.086. Epub 2007 Nov 7. Brain Res. 2008. PMID: 18048009 - Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L, Kieffer BL, Maldonado R, Berrendero F. Galeote L, et al. J Neurochem. 2006 Apr;97(2):416-23. doi: 10.1111/j.1471-4159.2006.03751.x. Epub 2006 Mar 15. J Neurochem. 2006. PMID: 16539669 - Endogenous opioids and smoking: a review of progress and problems.
Pomerleau OF. Pomerleau OF. Psychoneuroendocrinology. 1998 Feb;23(2):115-30. doi: 10.1016/s0306-4530(97)00074-7. Psychoneuroendocrinology. 1998. PMID: 9621393 Review.
Cited by
- Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model.
Luque-Sanchez K, Felix J, Bilbrey J, Restrepo L, Reeves M, McMahon LR, Wilkerson JL. Luque-Sanchez K, et al. Adv Drug Alcohol Res. 2023 Sep 11;3:11622. doi: 10.3389/adar.2023.11622. eCollection 2023. Adv Drug Alcohol Res. 2023. PMID: 38389808 Free PMC article. - The role of enkephalinergic systems in substance use disorders.
Rysztak LG, Jutkiewicz EM. Rysztak LG, et al. Front Syst Neurosci. 2022 Aug 5;16:932546. doi: 10.3389/fnsys.2022.932546. eCollection 2022. Front Syst Neurosci. 2022. PMID: 35993087 Free PMC article. Review. - Nicotine and opioid co-dependence: Findings from bench research to clinical trials.
Custodio L, Malone S, Bardo MT, Turner JR. Custodio L, et al. Neurosci Biobehav Rev. 2022 Mar;134:104507. doi: 10.1016/j.neubiorev.2021.12.030. Epub 2021 Dec 27. Neurosci Biobehav Rev. 2022. PMID: 34968525 Free PMC article. Review. - Enhancement of Opioid Antinociception by Nicotinic Ligands.
de Moura FB, Bergman J. de Moura FB, et al. J Pharmacol Exp Ther. 2021 Apr;377(1):100-107. doi: 10.1124/jpet.120.000423. Epub 2021 Jan 13. J Pharmacol Exp Ther. 2021. PMID: 33441370 Free PMC article. - Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.
Gibula-Tarlowska E, Kotlinska JH. Gibula-Tarlowska E, et al. Biomolecules. 2020 Sep 28;10(10):1376. doi: 10.3390/biom10101376. Biomolecules. 2020. PMID: 32998249 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous